New Delhi: With the Centre giving a go-ahead for Sputnik Light to be used as a booster dose, nearly 650,000 people who took the first dose of Sputnik V will now be able to access the vaccine at private vaccination centres, people familiar with the matter said on Friday.
“This week, component 1 of Sputnik V (or Sputnik Light) was approved for administration at private centres as the precaution dose for those who received Sputnik V as their primary vaccine. Having now received official confirmation of the approval, we are working with manufacturing partners in India…,” said Dr Reddy’s statement.
Pharma company Dr Reddy’s Laboratories, which has the rights for marketing and distribution to the Russian anti-Covid vaccine in India, has started discussions with the manufacturing partners, hospitals, and also with the government to make the option available on the CoWIN platform.
